Lower is better: implications of the Treating to New Targets (TNT) study for Canadian patients.
Vos
Eddie
E
D000069059:Atorvastatin; D002170:Canada; D008078:Cholesterol, LDL / Q000097:blood*; D050171:Dyslipidemias / Q000097:blood* / Q000188:drug therapy* / Q000401:mortality; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy / Q000401:mortality; D011758:Pyrroles / Q000627:therapeutic use
D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin